The GAD enrichment analysis indicates that the genes were significantly enriched for pancreatic neoplasms (p = 3.07E‐09), epithelial ovarian cancer (p = 4.18E‐08), bladder cancer (p = 5.27E‐08), lung cancer (p = 5.75E‐07), and breast cancer (p = 5.94E‐07). This evidence concerns the gene GAD1 and urinary bladder carcinoma.